Literature DB >> 19765358

Identification and management of familial hypercholesterolaemia: what does it mean to primary care?

Nadeem Qureshi1, Steve E Humphries, Mary Seed, Philip Rowlands, Rubin Minhas.   

Abstract

Familial hypercholesterolaemia is one of the most common dominantly inherited disorders to be identified in primary care, leading to raised serum cholesterol evident from the first year of life. Around 1 in 500 people are affected by this condition, but less than 15% of these are currently attending lipid clinics, suggesting that the vast majority are unrecognised in general practice. The recently released National Institute for Health and Clinical Excellence evidence-based guideline on the identification and management of familial hypercholesterolaemia provides an opportunity to bridge this gap. Primary care has a role in systematic and opportunistic case finding, such as recognising the relevance of a family history of premature coronary heart disease and/or grossly elevated cholesterol. Although affected individuals need specialist care, GPs can reinforce the information provided by specialists and support cascade screening to other affected members of the extended family.

Entities:  

Mesh:

Year:  2009        PMID: 19765358      PMCID: PMC2751920          DOI: 10.3399/bjgp09X472674

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  12 in total

1.  Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study.

Authors:  H A Neil; T Hammond; R Huxley; D R Matthews; S E Humphries
Journal:  BMJ       Date:  2000-07-15

2.  Oral contraceptives use and the risk of myocardial infarction: a meta-analysis.

Authors:  Yousef S Khader; Janet Rice; Lefante John; Osama Abueita
Journal:  Contraception       Date:  2003-07       Impact factor: 3.375

3.  Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis.

Authors:  Jean-Patrice Baillargeon; Donna K McClish; Paulina A Essah; John E Nestler
Journal:  J Clin Endocrinol Metab       Date:  2005-04-06       Impact factor: 5.958

4.  Census of clinics providing specialist lipid services in the United Kingdom.

Authors:  D Marks; M Thorogood; J M Farrer; S E Humphries
Journal:  J Public Health (Oxf)       Date:  2004-12       Impact factor: 2.341

5.  Disease knowledge and adherence to treatment in patients with familial hypercholesterolemia.

Authors:  Gunilla Hollman; Anders G Olsson; Anna-Christina Ek
Journal:  J Cardiovasc Nurs       Date:  2006 Mar-Apr       Impact factor: 2.083

6.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

Authors:  John C LaRosa; Scott M Grundy; David D Waters; Charles Shear; Philip Barter; Jean-Charles Fruchart; Antonio M Gotto; Heiner Greten; John J P Kastelein; James Shepherd; Nanette K Wenger
Journal:  N Engl J Med       Date:  2005-03-08       Impact factor: 91.245

Review 7.  A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia.

Authors:  Dalya Marks; Margaret Thorogood; H Andrew W Neil; Steve E Humphries
Journal:  Atherosclerosis       Date:  2003-05       Impact factor: 5.162

8.  Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.

Authors: 
Journal:  Atherosclerosis       Date:  1999-01       Impact factor: 5.162

9.  Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia.

Authors:  Agot Lia Amundsen; Janette Khoury; Per Ole Iversen; Caroline Bergei; Leiv Ose; Serena Tonstad; Kjetil Retterstøl
Journal:  Atherosclerosis       Date:  2006-02-08       Impact factor: 5.162

10.  Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.

Authors:  Andrew Neil; Jackie Cooper; John Betteridge; Nigel Capps; Ian McDowell; Paul Durrington; Mary Seed; Steve E Humphries
Journal:  Eur Heart J       Date:  2008-10-07       Impact factor: 29.983

View more
  15 in total

1.  Genetic advances in medicine: has the promise been fulfilled in general practice?

Authors:  Fiona M Walter; Jon D Emery
Journal:  Br J Gen Pract       Date:  2012-03       Impact factor: 5.386

2.  Familial hypercholesterolaemia.

Authors:  Serena Manning; Pippa Oakeshott
Journal:  Br J Gen Pract       Date:  2009-12       Impact factor: 5.386

3.  Commentary: What's so special about familial hypercholesterolaemia?

Authors:  David Mant
Journal:  Br J Gen Pract       Date:  2009-10       Impact factor: 5.386

4.  Introducing genetic testing with case finding for familial hypercholesterolaemia in primary care: qualitative study of patient and health professional experience.

Authors:  Luisa Silva; Laura Condon; Nadeem Qureshi; Brittany Dutton; Stephen Weng; Joe Kai
Journal:  Br J Gen Pract       Date:  2022-06-30       Impact factor: 6.302

Review 5.  Strategies for screening for familial hypercholesterolaemia in primary care and other community settings.

Authors:  Nadeem Qureshi; Maria Luisa R Da Silva; Hasidah Abdul-Hamid; Stephen F Weng; Joe Kai; Jo Leonardi-Bee
Journal:  Cochrane Database Syst Rev       Date:  2021-10-07

6.  Personalised medicine in general practice: the example of raised cholesterol.

Authors:  Nadeem Qureshi; Steve E Humphries; Huon Gray
Journal:  Br J Gen Pract       Date:  2018-02       Impact factor: 5.386

7.  Feasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development study.

Authors:  Nadeem Qureshi; Stephen Weng; Jennifer Tranter; Alia El-Kadiki; Joe Kai
Journal:  BMJ Open       Date:  2016-05-26       Impact factor: 2.692

8.  Assessment of physicians' awareness and knowledge of familial hypercholesterolemia in Saudi Arabia: Is there a gap?

Authors:  Mohammed Ali Batais; Turky H Almigbal; Aref A Bin Abdulhak; Hani B Altaradi; Khalid F AlHabib
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

Review 9.  Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.

Authors:  Ivan Pećin; Merel L Hartgers; G Kees Hovingh; Ricardo Dent; Željko Reiner
Journal:  Eur J Prev Cardiol       Date:  2017-06-23       Impact factor: 7.804

10.  An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study".

Authors:  Jing Pang; Miao Hu; Jie Lin; Takashi Miida; Hapizah M Nawawi; Jeong Euy Park; Xue Wu; Anis S Ramli; Ngoc Thanh Kim; See Kwok; Lourdes E Gonzalez-Santos; Ta-Chen Su; Thanh Huong Truong; Handrean Soran; Shizuya Yamashita; Brian Tomlinson; Gerald F Watts
Journal:  BMJ Open       Date:  2017-10-25       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.